Ampio Pharma treats first patient in Phase 1b AIK trial
The company expects to diagnose patients with a medical condition -pain and inflammation of the knee-osteoarthritis. In this study, Ampion is injected into the knees of patients with

The company expects to diagnose patients with a medical condition -pain and inflammation of the knee-osteoarthritis. In this study, Ampion is injected into the knees of patients with

Frik Ilac has a core portfolio of original prescription products both in primary care and specialist areas and employs 350 personnel, of which around 260 are medical representatives.

XARELTO, which belongs to a group of medicines called anticoagulants, works by blocking the blood clotting Factor Xa and thereby reduces the tendency of the blood to form

Sorrento Therapeutics will receive a total of $600,000, $300,000 annually for two years as Phase I grant. The company will also receive $1m per year for up to

Clinical trials conducted in Japan and overseas have confirmed that Rotarix prevents severe rotavirus gastroenteritis and all rotavirus gastroenteritis. The Ministry of Health, Labour and Welfare (MHLW) has

With this settlement, Glenmark can roll out its generic Colesevelam Hydrochloride products on 02 April 2015 or earlier under certain circumstances. At present Daiichi Sankyo markets the drug

NUTRILITE MEMORY BUILDER contains a complementary combination of standardized extracts of Ginkgo biloba and the herb Cistanche tubulosa. Preliminary research showed that the Cistanche extract helps protect and

Medtronic will receive a $3m upfront payment and up to $32m in regulatory and development milestone payments. Medtronic will also receive single-digit sales royalty if AC105 is commercialized

The study demonstrated the negative role that DR6 plays in regulating remyelination within the central nervous system. The dual role of DR6 antagonists in promoting remyelination and inhibiting

AAIPharma provides services that encompass the entire pharmaceutical drug development process from early development through commercialization. The successful FDA audit in Durham comes on the heels of two